XML 111 R82.htm IDEA: XBRL DOCUMENT v3.23.4
Commitments and Contingencies (Tables)
9 Months Ended 12 Months Ended
Sep. 30, 2023
Dec. 31, 2022
Commitments and Contingencies    
Schedule of lease cost

    

Nine Months 

 

Ended 

 

Operating Leases

September 30, 2023

 

Weighted average remaining lease term (years)

 

1.33

Weighted average discount rate

 

3.6

%

Year ending December 31,

    

2023

$

111,856

2024

459,749

2025

38,291

Total undiscounted lease payments

609,896

Imputed interest

(15,202)

Lease liability

$

594,694

 
Schedule of milestone payments the company shall pay to licensor  

Milestone Event

    

Amount

Enrollment of first patient in a phase II clinical trial of a therapeutic product or process

$

100,000

Enrollment of first patient in a phase III clinical trial of a therapeutic product or process

$

200,000

First commercial sale of a therapeutic product or process

$

1,000,000

Filing of an application for regulatory approval of a clinical diagnostic product or process

$

100,000

First regulatory approval of a clinical diagnostic product or process

$

150,000